EyeCRO are Experts in preclinical efficacy studies in ophthalmic retinopathy, pharmacokinetics, both in vivo and in vitro for clinical and precise formulation services and trial batteries. EyeCRO is a preclinical ophthalmic research organization focused on studies in retina preclinical efficacy, oxygen-induced retinopathy, and ophthalmic pharmacokinetics for clinical and precise formulation services and trial batteries. EyeCRO is a preclinical ophthalmic research organization focused on studies in Laser CNV, Retina preclinical efficacy, and Ophthalmic toxicology for clinical and precise formulation services.

Web developed by Josh Bolinger website design

The Global Leader in Preclinical Ophthalmic Research

Formulation and Bioanalytical

EyeCRO understands that not all test articles are freely integratable or readily bioavailable. By utilizing a combination of our formulation proficiency and historical awareness of vehicle suitability, we ensure an informed lead candidate selection process and a formulation suitable for your preclinical needs. Successful formulation development needs knowledge of the physicochemical characteristics of the drug. Therefore, we use preformulation screens prior to formal formulation development … Read More

Kala Pharmaceuticals Announces Positive Results from Phase 2 Trial of KPI-121 in Dry Eye Disease

Kala Pharmaceuticals, Inc. (Kala), a developer of innovative ophthalmic products based on its … Read More

Retinitis Pigmentosa: FDA approves first retinal implant for advanced adult RP

Retinitis pigmentosa (RP) is a group of inherited disorders characterized by progressive peripheral … Read More

More News

In-Vivo

EyeCRO provides numerous in-vivo research models to enable directed and meaningful preclinical drug discovery and development programs. EyeCRO also has extensive experience in various routes of administration and can customize studies depending on your needs. One of the main advantages in working with EyeCRO is our ability to be flexible. [Read More] … Read More

Ophthalmic Contract Research